INSP

INSPIRE MEDICAL SYSTEM Earnings Results: $INSP Reports Quarterly Earnings

INSPIRE MEDICAL SYSTEM ($INSP) posted quarterly earnings results on Monday, February 10th. The company reported earnings of $1.15 per share, beating estimates of $0.75 by $0.40. The company also reported revenue of $239,720,000, missing estimates of $241,744,804 by $-2,024,804.

You can see Quiver Quantitative's $INSP stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

INSPIRE MEDICAL SYSTEM Insider Trading Activity

INSPIRE MEDICAL SYSTEM insiders have traded $INSP stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.

Here’s a breakdown of recent trading of $INSP stock by insiders over the last 6 months:

  • RANDY BAN (Chief Commercial Officer) has made 0 purchases and 9 sales selling 21,000 shares for an estimated $4,032,945.
  • JOHN RONDONI (Chief Technology Officer) has made 0 purchases and 8 sales selling 13,792 shares for an estimated $2,652,009.
  • SHAWN MCCORMICK sold 800 shares for an estimated $176,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

INSPIRE MEDICAL SYSTEM Hedge Fund Activity

We have seen 174 institutional investors add shares of INSPIRE MEDICAL SYSTEM stock to their portfolio, and 185 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

INSPIRE MEDICAL SYSTEM Government Contracts

We have seen $3,654,390 of award payments to $INSP over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.


This article was originally published on Quiver News, read the full story.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.